New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 8, 2012
10:20 EDTEA, SYNC, NCMI, TNB, SIGA, MAKO, SNCR, RHHBY, ACM, EP, BP, ERJOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AECOM Technology (ACM) downgraded to Underperform from Buy at BofA/Merrill... BP (BP) downgraded to Underweight from Equal Weight at Barclays... El Paso (EP) downgraded to Underweight from Neutral at Atlantic Equities... Embraer (ERJ) downgraded to Neutral from Buy at Citigroup... Mako Surgical (MAKO) downgraded to Neutral from Buy at Mizuho... National CineMedia (NCMI) downgraded to In-Line from Outperform at Imperial Capital... Roche (RHHBY) downgraded to Neutral from Overweight at JPMorgan... SIGA Technologies (SIGA) downgraded to Sector Perform from Outperform at RBC Capital... Synacor (SYNC) downgraded to Underperform from Buy at BofA/Merrill... Synchronoss (SNCR) downgraded to Market Perform from Outperform at Wells Fargo... Thomas & Betts (TNB) downgraded to Neutral from Outperform at RW Baird... Electronic Arts (EA) downgraded to Market Perform from Outperform at William Blair.
News For ACM;BP;EP;ERJ;MAKO;NCMI;RHHBY;SIGA;SYNC;SNCR;TNB;EA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
June 24, 2015
19:53 EDTEAComcast to offer EA games over cable box, DSLReports says
Subscribe for More Information
10:36 EDTEAElectronic Arts advances after analysts positive on E3 showing
Subscribe for More Information
10:00 EDTEAOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:07 EDTRHHBYCAR-T cancer drug researchers seen as M&A targets, Bloomberg says
Juno Therapeutics (JUNO), Kite Pharma (KITE) and Bluebird Bio (BLUE) are trading well above their IPO levels as takeovers predictions have spurred interest and share increases for the developers of CAR-T gene therapies, said Bloomberg's "Real M&A" column, quoting Dimo Dimov, a professor at the University of Bath’s School of Management, as having said that companies such as Pfizer (PFE), Merck (MRK), Roche (RHHBY) and AstraZeneca (AZN) are "closely watching" the firms. Cellectis (CLLS), which is working with Pfizer on its own approach to CAR-T therapy, has said it wants to bring its therapy to market and doesn’t anticipate a sale, the report noted. Reference Link
07:33 EDTACMHouse Transportation & Infrastructure Committee to hold a hearing
Subscribe for More Information
07:19 EDTBPU.K. panel to decide on first fracking in area since 2011, WSJ reports
Subscribe for More Information
07:10 EDTEATake-Two upgraded to Buy with $35 target at Jefferies
Subscribe for More Information
07:09 EDTEAElectronic Arts price target raised to $75 from $66 at Brean Capital
Brean Capital raised its price target on Electronic Arts to $75 from $66 as they believe management's guidance may prove to be conservative. The firm also sees the company leading its peers on digital monetization on consoles and the cross-over into mobile. Brean Capital reiterated its Buy rating on Electronic Arts shares.
07:05 EDTEAElectronic Arts upgraded to Buy with $80 target at Jefferies
Jefferies upgraded Electronic Arts to Buy from Hold and raised its price target for the stock to $80. The firm views EA as well positioned amid faster than expected console sales and thinks the company's game pipeline is the best its ever been.
06:44 EDTEAElectronic Arts upgraded to Buy from Hold at Jefferies
Subscribe for More Information
June 23, 2015
08:03 EDTERJEmbraer Phenom jets ordered by Etihad Flight College
Subscribe for More Information
07:27 EDTEAJefferies to hold a conference
Subscribe for More Information
June 19, 2015
13:38 EDTACMOptions with decreasing implied volatility
Options with decreasing implied volatility: QIHU PIR RHT BLUE KMX RAD KBH ADBE ACM KR
10:00 EDTBPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:07 EDTERJEmbraer Defense & Security sells five A-29 Super Tucano to Ghana Air Force
Embraer Defense & Security and the Ministry of Defence of the Republic of Ghana have signed a contract for the acquisition of five A-29 Super Tucano light attack and advanced training turboprops. The contract includes logistic support for the operation of these aircraft as well as the set-up of a training system for pilots and mechanics in Ghana that will provide the autonomy of the Ghana Air Force in preparing qualified personnel. The A-29 Super Tucano will be deployed for advanced training, border surveillance and internal security missions. The contract will come into effect once certain conditions have been fulfilled. These conditions are expected to be fulfilled during the second half of 2015.
06:17 EDTBPRoyal Dutch Shell upgraded to Outperform from Sector Perform at RBC Capital
Subscribe for More Information
06:15 EDTBPBP downgraded to Sector Perform from Outperform at RBC Capital
Subscribe for More Information
06:13 EDTBPBP, Rosneft announce exploration and refining agreements
Rosneft and BP announced the signing of "several agreements strengthening the long term strategic relationship between the two companies." Rosneft and BP signed final binding agreements for Rosneft’s sale to BP of a 20% share of Taas-Yuryakh Neftegazodobycha, creating a new joint venture in East Siberia. Rosneft and BP have also agreed jointly to explore two additional Areas of Mutual Interest in the West Siberian and Yenisey-Khatanga basins covering a combined area of about 260,000 square kilometers. Any joint ventures will be owned 51% by Rosneft and 49% by BP. As part of this agreement Rosneft and BP will also form a joint venture to carry out further appraisal work on the 2009 Rosneft-discovered Baikalovskiy field inside the Yenisey-Khatanga AMI. Exploration activities in the two AMIs will include screening studies, acquisition of seismic data, and drilling of exploration wells as new licences are added. As a result of the planned deal Rosneft will double its shareholding in the Bayernoil refinery - to 25% from 12.5%; the MiRO refinery - to 24% from 12%; and the PCK Raffinerie - to 37.5% from 18.75%. BP in exchange will consolidate 100% of the equity of the Gelsenkirchen refinery and the solvent production facility DHC Solvent Chemie. The closing of the deal is subject to the fulfillment of conditions precedent, which include inter alia regulatory approvals.
June 18, 2015
07:54 EDTERJEmbraer upgraded to Outperform at Cowen
Subscribe for More Information
07:05 EDTERJEmbraer upgraded to Outperform from Market Perform at Cowen
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use